ATA Guidelines Tools

Adults with Differentiated THyroid Cancer - 2025 Update

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1540959

Contents of this Issue

Navigation

Page 30 of 49

31 Table 6. AJCC/UICC TNM Staging: The 8th Ed. TNM TNM Category a Code Description Primary tumor (pT) TX Primary tumor cannot be assessed T0 No evidence of primary tumor T1 Tumor ≤2 cm limited to thyroid • T1a Tumor ≤1 cm limited to thyroid • T1b Tumor >1 cm but ≤2 cm limited to thyroid T2 Tumor >2 cm but ≤4 cm limited to thyroid T3 Tumor >4 cm or minimal extrathyroidal extension • T3a Tumor >4 cm limited to thyroid • T3b Gross extrathyroidal extension to strap muscles T4 Gross extrathyroidal extension to major neck structures • T4a Invading so tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve • T4b Invading prevertebral fascia or encasing carotid/mediastinal vessels Regional lymph node (pN) NX Regional lymph nodes cannot be assessed N0 No evidence of regional lymph node metastasis • N0a One or more cytologic or histologically confirmed benign lymph nodes • N0b No radiologic/clinical evidence of metastasis N1 Metastasis to regional nodes • N1a Metastasis to level VI or VII (pretracheal, paratracheal, prelaryngeal/Delphian or upper mediastinal) lymph nodes; this can be unilateral or bilateral disease • N1b Metastasis to unilateral, bilateral or contralateral lateral neck lymph nodes (levels I, II, III, IV or V) or retropharyngeal lymph nodes Distant metastasis (M) M0 No distant metastasis M1 Distant metastasis present

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Adults with Differentiated THyroid Cancer - 2025 Update